tiprankstipranks
CVS Health Corp (GB:0HRS)
LSE:0HRS
UK Market
0HRS
CVS Health
RESEARCH TOOLSreports

CVS Health (0HRS) Share Forecast & Price Target

4 Followers
See the Price Targets and Ratings of:

0HRS Analyst Ratings

Strong Buy
17Ratings
Strong Buy
16 Buy
1 Hold
0 Sell
Based on 17 analysts giving stock ratings to
CVS
Health
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0HRS Stock 12 Month Forecast

Average Price Target

$96.33
▲(23.63% Upside)
Based on 17 Wall Street analysts offering 12 month price targets for CVS Health in the last 3 months. The average price target is $96.33 with a high forecast of $105.00 and a low forecast of $90.00. The average price target represents a 23.63% change from the last price of $77.92.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"59":"$59","106":"$106","70.75":"$70.8","82.5":"$82.5","94.25":"$94.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$105.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":96.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$96.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[59,70.75,82.5,94.25,106],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.5,75,77.5,80,82.5,85,87.5,90,92.5,95,97.5,100,102.5,{"y":105,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.5,74.33307692307692,76.16615384615385,77.99923076923076,79.8323076923077,81.66538461538461,83.49846153846154,85.33153846153846,87.16461538461539,88.9976923076923,90.83076923076923,92.66384615384615,94.49692307692308,{"y":96.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72.5,73.84615384615384,75.1923076923077,76.53846153846153,77.88461538461539,79.23076923076923,80.57692307692308,81.92307692307692,83.26923076923077,84.61538461538461,85.96153846153847,87.3076923076923,88.65384615384616,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":65.196,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.966,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.267,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.533,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":60.733,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.53,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.668,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.32,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.761,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 45,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.127,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.06,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.271,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.5,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$105.00Average Price Target$96.33Lowest Price Target$90.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on GB:0HRS
Lance Wilkes
Bernstein
Bernstein
$94
Buy
20.64%
Upside
Reiterated
04/10/26
Bernstein Remains a Buy on CVS Health (CVS)
RBC Capital Analyst forecast on GB:0HRS
Ben Hendrix
RBC Capital
RBC Capital
$93
Buy
19.35%
Upside
Reiterated
04/08/26
RBC Capital Remains a Buy on CVS Health (CVS)
Bank of America Securities Analyst forecast on GB:0HRS
Allen Lutz
Bank of America Securities
Bank of America Securities
$95
Buy
21.92%
Upside
Reiterated
04/07/26
Analysts Are Bullish on These Healthcare Stocks: CVS Health (CVS), Crispr Therapeutics AG (CRSP)
TD Cowen Analyst forecast on GB:0HRS
Charles Rhyee
TD Cowen
TD Cowen
$105
Buy
34.75%
Upside
Reiterated
04/07/26
Analysts Are Bullish on Top Healthcare Stocks: Outset Medical (OM), CVS Health (CVS)
Wells Fargo Analyst forecast on GB:0HRS
Stephen Baxter
Wells Fargo
Wells Fargo
$102
Buy
30.90%
Upside
Reiterated
04/02/26
CVS Health: Maintaining Buy Rating on Resilient Earnings Power and Above-Consensus 2026–2028 EPS Outlook
Piper Sandler Analyst forecast on GB:0HRS
Jessica Tassan
Piper Sandler
Piper Sandler
$101→$99
Buy
27.05%
Upside
Assigned
03/31/26
CVS Health price target lowered to $99 from $101 at Piper SandlerCVS Health price target lowered to $99 from $101 at Piper Sandler
Leerink Partners Analyst forecast on GB:0HRS
Michael Cherny
Leerink Partners
Leerink Partners
$98
Buy
25.77%
Upside
Reiterated
03/24/26
Analysts' Top Healthcare Picks: LENZ Therapeutics (LENZ), CVS Health (CVS)
Barclays Analyst forecast on GB:0HRS
Andrew Mok CFA
Barclays
Barclays
$93
Buy
19.35%
Upside
Reiterated
03/10/26
Barclays Sticks to Its Buy Rating for CVS Health (CVS)
Truist Financial Analyst forecast on GB:0HRS
David S Macdonald
Truist Financial
Truist Financial
$98
Buy
25.77%
Upside
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Staar Surgical (NASDAQ: STAA), CVS Health (NYSE: CVS) and Immunome (NASDAQ: IMNM)
Deutsche Bank Analyst forecast on GB:0HRS
George Hill
Deutsche Bank
Deutsche Bank
―
Buy
―
Reiterated
02/20/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Janux Therapeutics Inc (NASDAQ: JANX) and CVS Health (NYSE: CVS)
Oppenheimer Analyst forecast on GB:0HRS
Unknown Analyst
Oppenheimer
Not Ranked
Oppenheimer
―
Hold
―
Reiterated
02/11/26
Oppenheimer Keeps Their Hold Rating on CVS Health (CVS)
Evercore ISI Analyst forecast on GB:0HRS
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$95→$100
Buy
28.34%
Upside
Reiterated
02/11/26
Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS)
Goldman Sachs Analyst forecast on GB:0HRS
Scott Fidel
Goldman Sachs
Goldman Sachs
$95
Buy
21.92%
Upside
Reiterated
02/10/26
CVS Health: Strong Q4 Outperformance and Reinforced 2026 Guidance Support Buy Rating
Cantor Fitzgerald Analyst forecast on GB:0HRS
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$95
Buy
21.92%
Upside
Reiterated
02/10/26
Cantor Fitzgerald Remains a Buy on CVS Health (CVS)
Morgan Stanley Analyst forecast on GB:0HRS
Erin Wright
Morgan Stanley
Morgan Stanley
$93
Buy
19.35%
Upside
Reiterated
02/03/26
Analysts Conflicted on These Healthcare Names: CVS Health (NYSE: CVS), Madrigal Pharmaceuticals (NASDAQ: MDGL) and Xenon (NASDAQ: XENE)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bernstein Analyst forecast on GB:0HRS
Lance Wilkes
Bernstein
Bernstein
$94
Buy
20.64%
Upside
Reiterated
04/10/26
Bernstein Remains a Buy on CVS Health (CVS)
RBC Capital Analyst forecast on GB:0HRS
Ben Hendrix
RBC Capital
RBC Capital
$93
Buy
19.35%
Upside
Reiterated
04/08/26
RBC Capital Remains a Buy on CVS Health (CVS)
Bank of America Securities Analyst forecast on GB:0HRS
Allen Lutz
Bank of America Securities
Bank of America Securities
$95
Buy
21.92%
Upside
Reiterated
04/07/26
Analysts Are Bullish on These Healthcare Stocks: CVS Health (CVS), Crispr Therapeutics AG (CRSP)
TD Cowen Analyst forecast on GB:0HRS
Charles Rhyee
TD Cowen
TD Cowen
$105
Buy
34.75%
Upside
Reiterated
04/07/26
Analysts Are Bullish on Top Healthcare Stocks: Outset Medical (OM), CVS Health (CVS)
Wells Fargo Analyst forecast on GB:0HRS
Stephen Baxter
Wells Fargo
Wells Fargo
$102
Buy
30.90%
Upside
Reiterated
04/02/26
CVS Health: Maintaining Buy Rating on Resilient Earnings Power and Above-Consensus 2026–2028 EPS Outlook
Piper Sandler Analyst forecast on GB:0HRS
Jessica Tassan
Piper Sandler
Piper Sandler
$101→$99
Buy
27.05%
Upside
Assigned
03/31/26
CVS Health price target lowered to $99 from $101 at Piper SandlerCVS Health price target lowered to $99 from $101 at Piper Sandler
Leerink Partners Analyst forecast on GB:0HRS
Michael Cherny
Leerink Partners
Leerink Partners
$98
Buy
25.77%
Upside
Reiterated
03/24/26
Analysts' Top Healthcare Picks: LENZ Therapeutics (LENZ), CVS Health (CVS)
Barclays Analyst forecast on GB:0HRS
Andrew Mok CFA
Barclays
Barclays
$93
Buy
19.35%
Upside
Reiterated
03/10/26
Barclays Sticks to Its Buy Rating for CVS Health (CVS)
Truist Financial Analyst forecast on GB:0HRS
David S Macdonald
Truist Financial
Truist Financial
$98
Buy
25.77%
Upside
Reiterated
03/04/26
Analysts Offer Insights on Healthcare Companies: Staar Surgical (NASDAQ: STAA), CVS Health (NYSE: CVS) and Immunome (NASDAQ: IMNM)
Deutsche Bank Analyst forecast on GB:0HRS
George Hill
Deutsche Bank
Deutsche Bank
―
Buy
―
Reiterated
02/20/26
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (NASDAQ: GILD), Janux Therapeutics Inc (NASDAQ: JANX) and CVS Health (NYSE: CVS)
Oppenheimer Analyst forecast on GB:0HRS
Unknown Analyst
Oppenheimer
Not Ranked
Oppenheimer
―
Hold
―
Reiterated
02/11/26
Oppenheimer Keeps Their Hold Rating on CVS Health (CVS)
Evercore ISI Analyst forecast on GB:0HRS
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$95→$100
Buy
28.34%
Upside
Reiterated
02/11/26
Evercore ISI Sticks to Their Buy Rating for CVS Health (CVS)
Goldman Sachs Analyst forecast on GB:0HRS
Scott Fidel
Goldman Sachs
Goldman Sachs
$95
Buy
21.92%
Upside
Reiterated
02/10/26
CVS Health: Strong Q4 Outperformance and Reinforced 2026 Guidance Support Buy Rating
Cantor Fitzgerald Analyst forecast on GB:0HRS
Sarah James
Cantor Fitzgerald
Cantor Fitzgerald
$95
Buy
21.92%
Upside
Reiterated
02/10/26
Cantor Fitzgerald Remains a Buy on CVS Health (CVS)
Morgan Stanley Analyst forecast on GB:0HRS
Erin Wright
Morgan Stanley
Morgan Stanley
$93
Buy
19.35%
Upside
Reiterated
02/03/26
Analysts Conflicted on These Healthcare Names: CVS Health (NYSE: CVS), Madrigal Pharmaceuticals (NASDAQ: MDGL) and Xenon (NASDAQ: XENE)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering CVS Health

3 Months
xxx
Success Rate
15/23 ratings generated profit
65%
Average Return
+6.00%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +6.00% per trade.
1 Year
Elizabeth Anderson CFAEvercore ISI
Success Rate
17/23 ratings generated profit
74%
Average Return
+16.00%
Copying Elizabeth Anderson CFA's trades and holding each position for 1 Year would result in 73.91% of your transactions generating a profit, with an average return of +16.00% per trade.
2 Years
xxx
Success Rate
22/23 ratings generated profit
96%
Average Return
+25.22%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 95.65% of your transactions generating a profit, with an average return of +25.22% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0HRS Analyst Recommendation Trends

Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
0
0
0
0
0
Buy
45
28
34
21
21
Hold
3
6
7
5
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
48
34
41
26
22
In the current month, 0HRS has received 21 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 0HRS average Analyst price target in the past 3 months is 96.33.
Each month's total comprises the sum of three months' worth of ratings.

0HRS Financial Forecast

0HRS Earnings Forecast

Next quarter’s earnings estimate for 0HRS is $2.20 with a range of $2.09 to $2.38. The previous quarter’s EPS was $1.09. 0HRS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 0HRS has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0HRS is $2.20 with a range of $2.09 to $2.38. The previous quarter’s EPS was $1.09. 0HRS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 0HRS has Performed in-line its overall industry.

0HRS Sales Forecast

Next quarter’s sales forecast for 0HRS is $95.14B with a range of $90.97B to $98.92B. The previous quarter’s sales results were $105.68B. 0HRS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 0HRS has Performed in-line its overall industry.
Next quarter’s sales forecast for 0HRS is $95.14B with a range of $90.97B to $98.92B. The previous quarter’s sales results were $105.68B. 0HRS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 0HRS has Performed in-line its overall industry.

0HRS Stock Forecast FAQ

What is GB:0HRS’s average 12-month price target, according to analysts?
Based on analyst ratings, CVS Health Corp’s 12-month average price target is 96.33.
    What is GB:0HRS’s upside potential, based on the analysts’ average price target?
    CVS Health Corp has 23.63% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is CVS Health Corp a Buy, Sell or Hold?
          CVS Health Corp has a consensus rating of Strong Buy, which is based on 16 buy ratings, 1 hold ratings and 0 sell ratings.
            What is CVS Health Corp’s share price target?
            The average share price target for CVS Health Corp is 96.33. This is based on 17 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $105.00 ,and the lowest forecast is $90.00. The average share price target represents 23.63% Increase from the current price of $77.92.
              What do analysts say about CVS Health Corp?
              CVS Health Corp’s analyst rating consensus is a Strong Buy. This is based on the ratings of 17 Wall Streets Analysts.
                How can I buy shares of CVS Health Corp?
                To buy shares of GB:0HRS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.